Afabicin Uses, Dosage, Side Effects and more
Afabicin is under investigation in clinical trial NCT03723551 (Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus).
| Trade Name | Afabicin |
| Generic | Afabicin |
| Afabicin Other Names | Afabicin |
| Type | |
| Formula | C23H24N3O7P |
| Weight | Average: 485.433 Monoisotopic: 485.135187123 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
